latest update:
[RxAtlas]

drug summary · 2 NDC codes

UPTRAVI 400 ug/1

Selexipag

HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.

dataset id 90035NDC codes 2application NDA207947RxCUI —

Facts

Field definitions, types, and provenance rules are in the data dictionary.

generic nameSelexipag
active ingredientsSELEXIPAG
dosage formTABLET, COATED
routeORAL
strength400 ug/1
marketing statusNDA
DEA schedulenot reported
application numberNDA207947
ATC codenot reported
RxCUInot reported
manufacturerActelion Pharmaceuticals US, Inc.
product typeHUMAN PRESCRIPTION DRUG
pharmacologic classProstacyclin Receptor Agonist [EPC]; Prostacyclin Receptor Agonists [MoA]

NDC codes

2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.

NDCPackage description
66215-604—
66215060406—

Other Selexipag products

11 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.

Work with this record

  • Field definitions

    Types, scope, and provenance rules for every exported field.

  • REST API

    Query the same gate-backed records programmatically.

  • Evaluation sample

    Download a bounded slice before buying.

  • $29 API Pass

    Seven days of REST and MCP access to the full catalogue; credited toward the licence.